Key Takeaways
- Bloom Energy shares plummeted approximately 14% Thursday, retreating from the all-time high of $346 reached June 22.
- The decline occurred even as the company secured a $1.7 billion investment partnership to supply fuel cells for Nebius’ AI data center operations.
- Clear Street maintained its Hold position with a $290 valuation, characterizing the downturn as a tactical buying moment.
- Hunterbrook’s short report highlighted vulnerabilities in Bloom’s scandium procurement chain, particularly Chinese export dependencies.
- Analyst community consensus reflects a Moderate Buy stance, averaging $285.45 per share in price projections.
Shares of Bloom Energy experienced a significant downturn Thursday, declining approximately 14% before opening Friday trading at $205.94. This represents a substantial retreat from the company’s June 22 peak of $351.28.
Interestingly, this selloff coincided with positive corporate news: Bloom announced a major $1.7 billion investment commitment from IDF and Oaktree Capital to integrate its fuel cell technology into Nebius’ artificial intelligence cloud computing infrastructure.
In response to the market action, Clear Street analysts maintained their Hold recommendation alongside a $290 valuation, suggesting the price correction represents a transient reaction rather than a fundamental business deterioration.
“The current pullback appears to present an opportunistic moment,” the research team stated, highlighting the meaningful gap between trading levels and their target valuation.
Clear Street identified three primary catalysts driving the share price decline. First, AI-sector equities have broadly corrected since mid-June as market participants reassess whether current valuations appropriately discount anticipated capital expenditure levels in 2027 and 2028.
Second, emerging regulatory headwinds have introduced additional uncertainty. New York recently enacted legislation imposing a twelve-month moratorium on data center developments exceeding 50 MW capacity, sparking broader concerns about large-scale power infrastructure projects.
Third, research firm Hunterbrook published a bearish thesis highlighting vulnerabilities in Bloom’s scandium supply chain, noting that China controls the majority of global scandium production and is allegedly restricting export authorizations.
Supply Chain Vulnerability Under Scrutiny
Clear Street’s analysis acknowledged that concerns raised by Bloom’s previous chief financial officer primarily centered on late 2027 through 2028 timelines, as the company develops geographically diversified sourcing arrangements. The bearish report additionally questioned the structure of Bloom’s financing partnership with Brookfield and cited potential timeline extensions for Wyoming and New Mexico installations.
Nevertheless, the firm preserved its neutral outlook, arguing that long-range business fundamentals remain sound.
Institutional Positioning and Price Targets
Diversify Wealth Management initiated a BE position during Q1, acquiring 6,579 shares worth approximately $891,000. Multiple additional institutional investors expanded their stakes throughout the quarter, with institutional ownership now comprising 77.04% of BE stock.
Regarding insider transactions, Board Director John T. Chambers liquidated 55,000 shares in late May at approximately $297.69 each, generating proceeds exceeding $16.3 million. Executive Aman Joshi disposed of 8,343 shares July 1st at $300.37 per share.
Bloom’s latest quarterly financial results substantially exceeded Wall Street expectations. The organization reported earnings of $0.44 per share compared to the $0.12 consensus forecast, while revenue reached $751.05 million against projections of $539.94 million—representing 130.4% year-over-year growth.
Susquehanna elevated its valuation to $298 with a positive outlook on July 10. Robert W. Baird confirmed its outperform rating accompanied by a $310 target July 9. The current analyst consensus average price objective sits at $250.41, suggesting 38.08% appreciation potential from Friday’s opening price.
BE’s fifty-two-week trading range extends from $24.04 to $351.28.


